4
Changes in Ownership
Cue Biopharma, Inc. Filed Acc 0000899243-21-007232
Chief Medical Officer sold 20,274 shares at an average $15.13 ($306,767)
- Chief Medical Officer acquired 20,274 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pienta Kenneth Chief Medical Officer | 2021-02-16 | Option exercise | +16,000 | $2.86 | $45,760 | 18,000 | D |
| Pienta Kenneth Chief Medical Officer | 2021-02-16 | Sale | −16,000 | $15.15 | $242,422 | 2,000 | D |
| Pienta Kenneth Chief Medical Officer | 2021-02-17 | Option exercise | +1,280 | $2.86 | $3,661 | 3,280 | D |
| Pienta Kenneth Chief Medical Officer | 2021-02-17 | Option exercise | +2,994 | $5.00 | $14,970 | 6,274 | D |
| Pienta Kenneth Chief Medical Officer | 2021-02-17 | Sale | −4,274 | $15.06 | $64,345 | 2,000 | D |
| Derivatives | |||||||
| Pienta Kenneth Chief Medical Officer | 2021-02-16 | Option exercise · Stock Option (right to buy) | −16,000 | 1,280 | D | ||
| Pienta Kenneth Chief Medical Officer | 2021-02-17 | Option exercise · Stock Option (right to buy) | −1,280 | 0 | D | ||
| Pienta Kenneth Chief Medical Officer | 2021-02-17 | Option exercise · Stock Option (right to buy) | −2,994 | 147,006 | D | ||
| Open-market sales · 20,274 sh · avg $15.13 · $306,767 | |||||||
Loading xslF345X03/doc4.xml…